Plato Investment Management’s ResMed RMD Stock Holding History

Plato Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$774K	Hold	3,446	–	–	0.05%	296
2025 Q4	$834K	Hold	3,446	–	–	0.05%	288
2025 Q3	$936K	Hold	3,446	–	–	0.06%	271
2025 Q2	$886K	Buy	3,446 +4	+0.1%	+$954	0.07%	278
2025 Q1	$779K	Buy	3,442 +38	+1%	+$8.87K	0.07%	276
2024 Q4	$781K	Hold	3,404	–	–	0.06%	287
2024 Q3	$830K	Hold	3,404	–	–	0.07%	265
2024 Q2	$652K	Buy	3,404 +220	+7%	+$44.6K	0.06%	253
2024 Q1	$631K	Buy	3,184 +3,180	+79,500%	+$583K	0.07%	247
2023 Q4	$688	Buy	+4	New	+$615	﹤0.01%	450

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Plato Investment Management's RMD Position: Q1 2026 in Review

Plato Investment Management held its ResMed (RMD) position steady in Q1 2026 at 3,446 shares worth $774K. The position accounts for 0.05% of the portfolio, ranked #296.

Plato Investment Management first reported a position in RMD in Q4 2023 and has held it in 10 quarters since. The position peaked at $936K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Plato Investment Management held 3,446 shares of ResMed worth $774K as of Q1 2026.
Plato Investment Management left its ResMed share count unchanged in Q1 2026.
ResMed made up 0.05% of Plato Investment Management's portfolio in Q1 2026, its #296 holding.
Plato Investment Management first reported a position in ResMed in Q4 2023 and has held it in 10 quarters since.
Plato Investment Management's ResMed position peaked at $936K in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.